Central Nervous System B-Cell Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Central Nervous System B-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma (NCT03770416) | M.D. Anderson Cancer Center | 2019-02-15 |
Track Central Nervous System B-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.